Prognostic factors in metastatic breast cancer: Successes and challenges toward individualized therapy

被引：36

作者：

Andreopoulou, Eleni ^{[1
]}

Hortobagyi, Gabriel N. ^{[1
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 22期

关键词：

D O I：

10.1200/JCO.2008.16.1026

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：3660 / 3662

页数：3

共 11 条

[1]

Clarke M, 1998, LANCET, V351, P1451

[2] Circulating tumor cells, disease progression, and survival in metastatic breast cancer [J].

Cristofanilli, M ;

Budd, GT ;

Ellis, MJ ;

Stopeck, A ;

Matera, J ;

Miller, MC ;

Reuben, JM ;

Doyle, GV ;

Allard, WJ ;

Terstappen, LWMM ;

Hayes, DF .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (08) :781-791

[3] The hallmarks of cancer [J].

Hanahan, D ;

Weinberg, RA .

CELL, 2000, 100 (01) :57-70

[4] MULTIVARIATE-ANALYSIS OF PROGNOSTIC FACTORS IN METASTATIC BREAST-CANCER [J].

HORTOBAGYI, GN ;

SMITH, TL ;

LEGHA, SS ;

SWENERTON, KD ;

GEHAN, EA ;

YAP, HY ;

BUZDAR, AU ;

BLUMENSCHEIN, GR .

JOURNAL OF CLINICAL ONCOLOGY, 1983, 1 (12) :776-786

[5] HER-2 gene amplification can be acquired as breast cancer progresses [J].

Meng, SD ;

Tripathy, D ;

Shete, S ;

Ashfaq, R ;

Haley, B ;

Perkins, S ;

Beitsch, P ;

Khan, A ;

Euhus, D ;

Osborne, C ;

Frenkel, E ;

Hoover, S ;

Leitch, M ;

Clifford, E ;

Vitetta, E ;

Morrison, L ;

Herlyn, D ;

Terstappen, LWMM ;

Fleming, T ;

Fehm, T ;

Tucker, T ;

Lane, N ;

Wang, JQ ;

Uhr, J .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (25) :9393-9398

[6]

Nagata Y, 2004, CANCER CELL, V6, P117, DOI 10.1016/j.ccr.2004.06.022

[7] Molecular portraits of human breast tumours [J].

Perou, CM ;

Sorlie, T ;

Eisen, MB ;

van de Rijn, M ;

Jeffrey, SS ;

Rees, CA ;

Pollack, JR ;

Ross, DT ;

Johnsen, H ;

Akslen, LA ;

Fluge, O ;

Pergamenschikov, A ;

Williams, C ;

Zhu, SX ;

Lonning, PE ;

Borresen-Dale, AL ;

Brown, PO ;

Botstein, D .

NATURE, 2000, 406 (6797) :747-752

[8] Microtubule-associated protein tau: A marker of paclitaxel sensitivity in breast cancer [J].

Rouzier, R ;

Rajan, R ;

Wagner, P ;

Hess, KR ;

Gold, DL ;

Stec, J ;

Ayers, M ;

Ross, JS ;

Zhang, P ;

Buchholz, TA ;

Kuerer, H ;

Green, M ;

Arun, B ;

Hortobagyi, GN ;

Symmans, WF ;

Pusztai, L .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (23) :8315-8320

[9] Mechanisms of tamoxifen resistance: Increased estrogen receptor-HER2/neu cross-talk in ER/HER2-positive breast cancer [J].

Shou, J ;

Massarweh, S ;

Osborne, CK ;

Wakeling, AE ;

Ali, S ;

Weiss, H ;

Schiff, R .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (12) :926-935

[10] Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. [J].

Slamon, DJ ;

Leyland-Jones, B ;

Shak, S ;

Fuchs, H ;

Paton, V ;

Bajamonde, A ;

Fleming, T ;

Eiermann, W ;

Wolter, J ;

Pegram, M ;

Baselga, J ;

Norton, L .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (11) :783-792

← 1 2 →